作者: Tali Benromano , Veronica Lifshitz , Dan Frenkel , Adi Kopelevich , Nofit Borenstein
DOI:
关键词: Virus 、 Peptide 、 Diabetes mellitus 、 Retinal damage 、 Enzyme 、 Peptide sequence 、 Amino acid 、 Biology 、 Biochemistry
摘要: Use of an isolated peptide comprising amino acid sequence being no more than 25 acids in length, the at least one aspartate or a homolog thereof, having Insulin-Degrading Enzyme (IDE) inhibitory activity, for manufacture medicament identified treating disease selected from group consisting diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve microvascular damage and varicella-zoster virus (VZV) infection is disclosed.